Calendar Daxor Corporation Nyse

Equities

DXR

US2394671034

Market Closed - Nyse 21:30:00 26/04/2024 BST 5-day change 1st Jan Change
9.65 USD 0.00% Intraday chart for Daxor Corporation -0.92% +0.52%

Chart calendar Daxor Corporation

c6f9ddb37f43879ce12c1e1.1oYrwwLXV8OiYP_U4a3J49l7uHqHKgnwM7Gm0JuPbMg.pcJolTX6ApbxC4Wxk-L6gqgu3hfMW2ejS5zcj8LoD6Xhy36VZZ4_oOFVqg~2a23a9c6b7092203d242f6da14591761

Upcoming events on Daxor Corporation

21/08/2024 Q2 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)
20/08/2025 Q2 2025 Earnings Release (Projected)
25/02/2026 Q4 2025 Earnings Release (Projected)

Past events on Daxor Corporation

17/04/2024 MedAxiom CV Transforum Spring Conference
05/04/2024 American College of Cardiology Scientific Meeting
25/03/2024 20:00 Q4 2023 Earnings Call
18/03/2024 18:18 Q4 2023 Earnings Release
03/03/2024 Technology and Heart Failure Therapeutics Conference
31/01/2024 Society of Nuclear Medicine and Molecular Imaging Mid Winter and American College Nuclear Medicine M
20/01/2024 Society for Critical Care Medicine Congress
07/10/2023 Heart Failure Society of America Meeting
07/10/2023 Heart Failure Society Scientific Conference
05/10/2023 Heart Failure Society Scientific Meeting - Poster #339
04/10/2023 MedAxiom CV Transforum Fall Conference
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
28/06/2023 American Association of Heart Failure Nurses Meeting
21/06/2023 20:30 Maxim Group Virtual Healthcare Conference
19/04/2023 MedAxiom CV Transforum Spring Conference
18/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #117.532
18/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #116.531
18/04/2023 International Society for Heart and Lung Transplant Meeting - Poster #118.537
19/03/2023 Technology Heart Failure Therapeutics Conference
02/03/2023 14:00 Q4 2022 Earnings Call

Past dividends on Daxor Corporation

04/01/2018 Annual 0.03 USD
19/12/2016 Annual 0.03 USD
17/12/2015 0.04 USD
03/12/2014 0.03 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
0,38
0,39
-3.5%
0,26
3,50
-92.44%
0,28
0,13
120.71%
EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,60
-
0,00
0,00
-
EBIT
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-0,50
0,21
-332.47%
0,00
0,00
-
4,75
-1,55
406.93%
Net income
Million USD
Released
Forecast
Spread
-0,50
0,32
-254.89%
0,00
0,00
-
4,75
-1,55
406.53%
EPS
USD
Released
Forecast
Spread
-0,13
0,08
-265.38%
-0,42
0,15
-381.33%
0,00
0,00
-
Announcement Date28/02/2025/02/2128/02/22

Quarterly results

Fiscal PeriodDecember 2021 S1
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-1,55


Net income
Million USD
Released
Forecast
Spread
-1,55


Announcement Date30/08/21

Net sales - Annual - Rate of surprise